Apitope News

Latest Press Releases

Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment

May 18, 2010

Bristol, UK / Hasselt, Belgium – 18th May 2010 – Apitope, the European Biotech Company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second phase 1 clinical trial of ATX-MS-1467, in patients with Multiple Sclerosis (MS). MS is a chronic, inflammatory condition of the nervous system and is…

Details